Post hoc subgroup analysis and the truth of a clinical trial

被引：23

作者：

Adams, KF ^{[1
]}

机构：

[1] Univ N Carolina, Chapel Hill, NC USA

来源：

AMERICAN HEART JOURNAL | 1998年 / 136卷 / 05期

关键词：

D O I：

10.1016/S0002-8703(98)70116-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：753 / 758

页数：6

共 22 条

[1] [Anonymous], 1988, LANCET, V2, P349
[2] [Anonymous], 1990, Lancet, V336, P1
[3] Feldman A., 1997, Journal of the American College of Cardiology, V29, p64A
[4] EFFECTS OF VESNARINONE ON MORBIDITY AND MORTALITY IN PATIENTS WITH HEART-FAILURE
FELDMAN, AM
BRISTOW, MR
PARMLEY, WW
CARSON, PE
PEPINE, CJ
GILBERT, EM
STROBECK, JE
HENDRIX, GH
POWERS, ER
BAIN, RP
WHITE, BG
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) : 149 - 155
[5] TESTING FOR QUALITATIVE INTERACTIONS BETWEEN TREATMENT EFFECTS AND PATIENT SUBSETS
GAIL, M
SIMON, R
[J]. BIOMETRICS, 1985, 41 (02) : 361 - 372
[6] APPROXIMATE MULTINORMAL PROBABILITIES APPLIED TO CORRELATED MULTIPLE END-POINTS IN CLINICAL-TRIALS
JAMES, S
[J]. STATISTICS IN MEDICINE, 1991, 10 (07) : 1123 - 1135
[7] Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathy
Kass, DA
VanAnden, E
Becker, LC
Kasper, EK
White, WB
Feldman, AM
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (06) : 652 - 656
[8] Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart
Kitakaze, M
Minamino, T
Funaya, H
Node, K
Shinozaki, Y
Mori, H
Hori, M
[J]. CIRCULATION, 1997, 95 (08) : 2108 - 2114
[9] CLINICAL JUDGMENT AND STATISTICS - LESSONS FROM A SIMULATED RANDOMIZED TRIAL IN CORONARY-ARTERY DISEASE
LEE, KL
MCNEER, JF
STARMER, CF
HARRIS, PJ
ROSATI, RA
[J]. CIRCULATION, 1980, 61 (03) : 508 - 515
[10] VESNARINONE, A NEW INOTROPIC AGENT, INHIBITS CYTOKINE PRODUCTION BY STIMULATED HUMAN BLOOD FROM PATIENTS WITH HEART-FAILURE
MATSUMORI, A
SHIOI, T
YAMADA, T
MATSUI, S
SASAYAMA, S
[J]. CIRCULATION, 1994, 89 (03) : 955 - 958

← 1 2 3 →